Technical Analysis for MTCR - Metacrine, Inc.

Grade Last Price % Change Price Change
F 5.21 -0.95% -0.05
MTCR closed down 0.95 percent on Friday, April 9, 2021, on 1.45 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical MTCR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
NR7 Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -0.95%
Volume Surge Other -0.95%
New 52 Week Low Weakness -0.95%
Wide Bands Range Expansion -0.95%
Older End-of-Day Signals for MTCR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago
1.5x Volume Pace 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Metacrine is a clinical-stage biopharmaceutical company building a differentiated pipeline of therapies to treat liver and gastrointestinal (GI) diseases. The company’s most advanced programs, MET409 and MET642, target the farnesoid X receptor (FXR), which is central to modulating liver and GI diseases. Both MET409 and MET642 are currently being investigated in clinical trials as potential new treatments for non-alcoholic steatohepatitis (NASH).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Diseases Alcohol Chemical Compounds Gastrointestinal Specialty Drugs Steatohepatitis Hepatitis Non Alcoholic Fatty Liver Disease Gastrointestinal Disease Carboxylic Acids Farnesoid X Receptor Fxr Gi Disease

Is MTCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.19
52 Week Low 5.16
Average Volume 67,657
200-Day Moving Average 0.00
50-Day Moving Average 8.42
20-Day Moving Average 6.89
10-Day Moving Average 5.93
Average True Range 0.52
ADX 40.15
+DI 10.82
-DI 36.96
Chandelier Exit (Long, 3 ATRs ) 8.02
Chandelier Exit (Short, 3 ATRs ) 6.72
Upper Bollinger Band 9.05
Lower Bollinger Band 4.72
Percent B (%b) 0.11
BandWidth 62.88
MACD Line -0.90
MACD Signal Line -0.76
MACD Histogram -0.1392
Fundamentals Value
Market Cap 135.23 Million
Num Shares 26 Million
EPS
Price-to-Sales 0.00
Price-to-Book 2.11
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.65
Resistance 3 (R3) 5.69 5.57 5.58
Resistance 2 (R2) 5.57 5.46 5.55 5.55
Resistance 1 (R1) 5.39 5.39 5.33 5.36 5.53
Pivot Point 5.28 5.28 5.25 5.26 5.28
Support 1 (S1) 5.10 5.16 5.04 5.06 4.89
Support 2 (S2) 4.98 5.09 4.96 4.87
Support 3 (S3) 4.80 4.98 4.84
Support 4 (S4) 4.77